ϸ°ûÉúÎïѧ£º s[nXr
Ò»¡¢ Ãû´Ê½âÊÍ£º D@!`b6
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© 8k2prv^
2£® PCR£¨96£© jAf
Uz7@
3£® ·ºËØ£¨ubquitin£©£¨96£© Z9cch-u~
4£® °é·Ö×Ó£¨chapron£©£¨96£© (WCpaC
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© lV]hjt-L
2
6£® DG£IP3£¨96£© y'*^ '
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© HY~\e|o
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© =PP]LDlJs
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© &7,Kv0j}
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© ,jQkR^]j-
11£® Transformation£¨92£© j0>S)Q
12£® TransfectionתȾ£¨92£© ,6~c0]/
13£® TranscytosisתÒÆ×÷Óã¨92£© $^INl0Pg
14£® Transductionתµ¼£¨92£© 8OqG{jmG
15£® Transdetermination£¨92£© *JZU
0Xb
16£® Transdifferentiation£¨92£© yP :>vFd7
17£® Transgenic animalת»ùÒò¶¯Î92£© [a53H$`\5
18£® Rb£1£¨92£© CtTG`)"|
19£® P53£¨92¡¢91£© 4>uz'j<
20£® C£jun£¨92£© ) 2wof(
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© Y\(Q
22£® °ûÄÚÌ壨99£© #
5v 2`|)
23£® Cyclin dependent kinase inhibitor(CDKI)(99) sl}bNzT#
24£® G£protein£¨91£© *^bqpW2$q
25£® Restriction point£¨91£© KXL]Qw FN
26£® Antipost£¨91£© sOa`T k
27£® Capping£¨91£© r50}j
28£® TATAbox£¨91£© hzg&OW=:
29£® cDNA library£¨90£© nmn$$=~)
30£® Aritotic apparatus£¨90£© N8m|Y]^H#
31£® ¿çĤÐźŠtransmembrane signal£¨90£© Vl5
}m
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© \om$%FUP
33£® Nuclear lamina£¨90£© [h""AJ~t
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© ~P
1(%FZ
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© yw41/jHF
36£® ϸ°û·Ö»¯£¨00£© E)H:
L-
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© j+\I4oFN
38£® ¿Ë¡£¨00£© EjV,&7o)
39£® »ùÒò×飨00£© dms R>Q
40£® Caspase£¨00£© 3kx/Q#
41£® ת¼Òò×Ó£¨00£© |!euty ::
42£® ÅßÌ¥¸Éϸ°û£¨01£© /zMiy?
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© 8`Q8Mct$<
44£® DNAоƬ£¨01£© cx_FtD
¶þ¡¢ ÎÊ´ðÌ⣺ r@5_LD@f
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© |G&<@8O
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æ书ÄÜ£¨95£© SL zL/5s
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© &Ey5 H?U!
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© kzny4v[y
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© d@#!,P5`
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© 'e^,#L_!o
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© IeLG/ fB
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© AP'UcA
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© 8ME_O~,N
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿Øϸ°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© J3KY?,g3O_
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷Íƶ¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£©
Y*/:IYr`
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© 6+u}'mSj8
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© f=]+\0MQ
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© 6S)$wj*w
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹Øϵ£¨95£© j9)P3=s
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© r1b{G%;mJ
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æ书ÄÜ£¨93£© _TfG-Ae
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© ^2%_AP0=
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© DP ,owk
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æ䶨λ¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© ~XQj0'
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäÄ¿Ç°ËùÖªµÄ¹¦ÄÜ£¨01£© @8E mY,{;
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖصãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© c,pR+DP
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© 2eo]D
?}
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© Wj.f$U4
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© QH@?.Kb_qU
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆڵĵ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© ,e$]jC<sv2
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹Øϵ£¨91£© J}U); A
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© :tU&d(8
29£® ÊÔÊöºáÎƼ¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© RnC96"";R.
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æ书ÄÜ£¨95£©
hEla8L4Y
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© |YCGWJaci
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© ,rj_P
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© {JTO
Q 8&
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© V'?bZcRr~
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©